1![An ‘Impossible Typology’? Pluriactivity and Multi-functionality of Rural Households in Greece An ‘Impossible Typology’? Pluriactivity and Multi-functionality of Rural Households in Greece](https://www.pdfsearch.io/img/d072e0c7347270a5b423977ae07769aa.jpg) | Add to Reading ListSource URL: www.cofami.orgLanguage: English - Date: 2014-08-27 03:21:16
|
---|
2![Investors News Release NEWS RELEASE Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition Investors News Release NEWS RELEASE Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition](https://www.pdfsearch.io/img/12c53169d46423a0ace50dbd1fa95c8e.jpg) | Add to Reading ListSource URL: www.athyrium.comLanguage: English - Date: 2015-03-12 22:05:58
|
---|
3![NEWS RELEASE For Immediate Release IKARIA Announces In-Licensing of “Thyronamine Technology” from the University of California, San Francisco and Oregon Health & Science University Ikaria, a Seattle biotechnology com NEWS RELEASE For Immediate Release IKARIA Announces In-Licensing of “Thyronamine Technology” from the University of California, San Francisco and Oregon Health & Science University Ikaria, a Seattle biotechnology com](https://www.pdfsearch.io/img/55ecfa205f1bb477df51c5c0aa2b24e0.jpg) | Add to Reading ListSource URL: www.ikaria.comLanguage: English - Date: 2011-06-28 11:53:09
|
---|
4![FOR IMMEDIATE RELEASE FDA ACCEPTS FINAL SECTION OF NDA FILING FOR LUCASSIN® -- Priority Review Granted -Lebanon, NJ, and Clinton, NJ, June 12, 2009 – Orphan Therapeutics, LLC and Ikaria Holdings, Inc. announced today FOR IMMEDIATE RELEASE FDA ACCEPTS FINAL SECTION OF NDA FILING FOR LUCASSIN® -- Priority Review Granted -Lebanon, NJ, and Clinton, NJ, June 12, 2009 – Orphan Therapeutics, LLC and Ikaria Holdings, Inc. announced today](https://www.pdfsearch.io/img/337e632d02618d7963c327a3f16f1038.jpg) | Add to Reading ListSource URL: www.ikaria.comLanguage: English - Date: 2011-06-28 11:52:57
|
---|
5![CONTACTS Matthew Bennett Ikaria[removed]removed] CONTACTS Matthew Bennett Ikaria[removed]removed]](https://www.pdfsearch.io/img/d653ac43b041827cbf9ae24a2829784a.jpg) | Add to Reading ListSource URL: www.ikaria.comLanguage: English - Date: 2011-06-28 11:52:46
|
---|
6![MEDIA CONTACTS Liz Larkin Ikaria[removed]removed] MEDIA CONTACTS Liz Larkin Ikaria[removed]removed]](https://www.pdfsearch.io/img/1a606f2b9e9d53341c96c67e17a1d551.jpg) | Add to Reading ListSource URL: www.ikaria.comLanguage: English - Date: 2011-06-28 11:52:43
|
---|
7![IKARIA® NAMES NEW HEAD OF RESEARCH & DEVELOPMENT Clinton, NJ, June 1, 2010 – Ikaria, Inc. today announced that Douglas Greene, M.D., has been appointed Executive Vice President of Research and Development (R&D). In th IKARIA® NAMES NEW HEAD OF RESEARCH & DEVELOPMENT Clinton, NJ, June 1, 2010 – Ikaria, Inc. today announced that Douglas Greene, M.D., has been appointed Executive Vice President of Research and Development (R&D). In th](https://www.pdfsearch.io/img/2e96b672d47bb62b2c717cdf90ad9331.jpg) | Add to Reading ListSource URL: www.ikaria.comLanguage: English - Date: 2011-06-28 11:52:59
|
---|
8![IKARIA® NAMES NEW CHIEF FINANCIAL OFFICER Clinton, NJ, July 8, 2010 – Ikaria, Inc. today announced that Craig Tooman will join Ikaria as Senior Vice President and Chief Financial Officer (CFO). In this role, Mr. Tooma IKARIA® NAMES NEW CHIEF FINANCIAL OFFICER Clinton, NJ, July 8, 2010 – Ikaria, Inc. today announced that Craig Tooman will join Ikaria as Senior Vice President and Chief Financial Officer (CFO). In this role, Mr. Tooma](https://www.pdfsearch.io/img/17945c0cfec5b4955d9235bab675871a.jpg) | Add to Reading ListSource URL: www.ikaria.comLanguage: English - Date: 2011-06-28 11:53:03
|
---|
9![IKARIA® TO PRESENT AT 2011 BIO INVESTOR FORUM Hampton, NJ, October 18, 2011 – Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant ne IKARIA® TO PRESENT AT 2011 BIO INVESTOR FORUM Hampton, NJ, October 18, 2011 – Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant ne](https://www.pdfsearch.io/img/4300785da1b72c8b94f8378263b4bd77.jpg) | Add to Reading ListSource URL: www.ikaria.comLanguage: English - Date: 2011-12-21 11:15:11
|
---|
10![Press Release - CEO Appointment - Final[removed]doc Press Release - CEO Appointment - Final[removed]doc](https://www.pdfsearch.io/img/ff88b2e64766f45c0028edcaeb29b5b3.jpg) | Add to Reading ListSource URL: www.ikaria.comLanguage: English - Date: 2011-06-28 11:52:53
|
---|